Letters
Lipid lowering drugs in diabetes: Abstract was misleading
BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7552.1272 (Published 25 May 2006) Cite this as: BMJ 2006;332:1272
- Mieke L van Driel, editor, Minerva Belgian Journal for Evidence Based Medicine (mieke.vandriel@ugent.be),
- Pierre Chevalier, editor, Minerva Belgian Journal for Evidence Based Medicine
- Department of General Practice and Primary Health Care, Ghent University, De Pintelaan 185 UZ 1K3, B-9000 Ghent, Belgium
- Centre Universitaire de Médecien Générale, Université Catholique de Louvain, Belgium
EDITOR—The meta-analysis by Costa et al tackles clinically relevant issues by evaluating the effect of lipid lowering treatment in primary compared with secondary prevention and diabetic patients compared with non-diabetic patients.1 The authors' conclusions as reported in the abstract may have important implications for guide-line recommendations and marketing of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.